Hematology/Oncology

Top Story

Stanford, Johns Hopkins cancer researchers share Albany Prize

Stanford, Johns Hopkins cancer researchers share Albany Prize
August 23, 2019
In the JournalsPerspective

High-volume, NCI-designated centers not associated with greater value in pancreatic cancer care

August 23, 2019
High-value care appeared associated with important patient, tumor and treatment characteristics among patients with early-stage pancreatic cancer who underwent curative…
In the Journals

Cancer prevalence higher in women with OSA

August 23, 2019
Obstructive sleep apnea is associated with an increased risk for cancer in women, a recent analysis of the European Sleep Apnoea Database study suggests. “The…
In the Journals

Cancer survivors at higher medium-, long-term risk for cardiovascular disease

August 23, 2019
Survivors of most types of cancers demonstrated increased medium- to long-term risk for at least one cardiovascular disease compared with the general population…
Advanced Practice

Nephrotoxicity among young patients with cancer: Not only an acute problem

HemOnc Today, August 25, 2019
Lisa Triche, DNP, RN, CPNP
Balancing long-term risks and benefits of potentially toxic therapies, while achieving a cure, remains a delicate challenge in cancer treatment. Nephrotoxicity — a…
More Headlines »
CME

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »
Video
Meeting News

VIDEO: Servier Pharmaceuticals executive highlights pipeline, ‘focus on the patients’

June 28, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer

CME ABIM MOC

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next